Naked Cuticle Homolog 2 Controls the Differentiation of Osteoblasts and Osteoclasts and Ameliorates Bone Loss in Ovariectomized Mice

Overview

Journal Genes Dis

Date 2024 Nov 18

PMID 39552785

Authors

Liying Shan

Xiaoxia Liao

Xiaoli Yang

Endong Zhu

Hairui Yuan

Jie Zhou

Xiaoxia Li

Baoli Wang

Affiliations

Soon will be listed here.

Abstract

Naked cuticle homolog 2 (NKD2) has been recognized as an antagonist of Wnt/β-catenin signaling and a tumor suppressor. The role of NKD2 in osteoblast and osteoclast differentiation and the mechanism are not fully understood. In this study, we identified the up-regulation of NKD2 during osteoblast and adipocyte differentiation. Functional experiments revealed that NKD2 stimulated osteoblast differentiation and suppressed adipocyte formation. Furthermore, NKD2 down-regulated the expression of receptor activator of nuclear factor-κB ligand in bone marrow mesenchymal stem cells and inhibited osteoclast formation from osteoclast precursor cells. Mechanistic investigations revealed that the regulation of osteoblast and adipocyte differentiation by NKD2 involved Wnt/β-catenin and tuberous sclerosis complex subunit 1 (TSC1)/mechanistic target of rapamycin complex 1 (mTORC1) signaling pathways. Unlike in undifferentiated mesenchymal cells where NKD2 promoted Dishevelled-1 degradation, in the cells differentiating toward osteoblasts or adipocytes NKD2 down-regulated secreted frizzled related protein 1/4 expression and failed to destabilize Dishevelled-1, thereby activating Wnt/β-catenin signaling. Moreover, NKD2 bound to TSC1 and inhibited mTORC1 signaling. Further investigation uncovered an interplay between TSC1/mTORC1 and Wnt/β-catenin signaling pathways. Finally, transplantation of NKD2-overexpressing bone marrow mesenchymal stem cells into the marrow of mice increased osteoblasts, reduced osteoclasts and marrow fat, and partially prevented bone loss in ovariectomized mice. This study provides evidence that NKD2 in mesenchymal stem/progenitor cells reciprocally regulates the differentiation of osteoblasts and adipocytes by modulating Wnt/β-catenin and mTORC1 pathways and inhibits osteoclast formation by down-regulating receptor activator of nuclear factor-κB ligand. It suggests that NKD2 up-regulation may ameliorate postmenopausal bone loss.

References

Claudel M, Jouzeau J, Cailotto F . Secreted Frizzled-related proteins (sFRPs) in osteo-articular diseases: much more than simple antagonists of Wnt signaling?. FEBS J. 2019; 286(24):4832-4851. DOI: 10.1111/febs.15119. View

Wu M, Chen G, Li Y . TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 2016; 4:16009. PMC: 4985055. DOI: 10.1038/boneres.2016.9. View

Hu T, Li C, Cao Z, Van Raay T, Smith J, Willert K . Myristoylated Naked2 antagonizes Wnt-beta-catenin activity by degrading Dishevelled-1 at the plasma membrane. J Biol Chem. 2010; 285(18):13561-8. PMC: 2859517. DOI: 10.1074/jbc.M109.075945. View

Zhou H, Zhang L, Chen Y, Zhu C, Chen F, Li A . Research progress on the hedgehog signalling pathway in regulating bone formation and homeostasis. Cell Prolif. 2021; 55(1):e13162. PMC: 8780935. DOI: 10.1111/cpr.13162. View

Zhang J, Fu M, Cui T, Xiong C, Xu K, Zhong W . Selective disruption of PPARgamma 2 impairs the development of adipose tissue and insulin sensitivity. Proc Natl Acad Sci U S A. 2004; 101(29):10703-8. PMC: 489998. DOI: 10.1073/pnas.0403652101. View

Zhao S, Kurenbekova L, Gao Y, Roos A, Creighton C, Rao P . NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma. Oncogene. 2015; 34(39):5069-79. PMC: 4802362. DOI: 10.1038/onc.2014.429. View

Marie P . Targeting integrins to promote bone formation and repair. Nat Rev Endocrinol. 2013; 9(5):288-95. DOI: 10.1038/nrendo.2013.4. View

Hiraiwa M, Ozaki K, Yamada T, Iezaki T, Park G, Fukasawa K . mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis. Front Pharmacol. 2019; 10:684. PMC: 6585391. DOI: 10.3389/fphar.2019.00684. View

Berendsen A, Olsen B . Osteoblast-adipocyte lineage plasticity in tissue development, maintenance and pathology. Cell Mol Life Sci. 2013; 71(3):493-7. PMC: 3947173. DOI: 10.1007/s00018-013-1440-z. View

10.

Abdallah B, Jafari A, Zaher W, Qiu W, Kassem M . Skeletal (stromal) stem cells: an update on intracellular signaling pathways controlling osteoblast differentiation. Bone. 2014; 70:28-36. DOI: 10.1016/j.bone.2014.07.028. View

11.

Chen Q, Shou P, Zheng C, Jiang M, Cao G, Yang Q . Fate decision of mesenchymal stem cells: adipocytes or osteoblasts?. Cell Death Differ. 2016; 23(7):1128-39. PMC: 4946886. DOI: 10.1038/cdd.2015.168. View

12.

Wang J, Liu S, Li J, Zhao S, Yi Z . Roles for miRNAs in osteogenic differentiation of bone marrow mesenchymal stem cells. Stem Cell Res Ther. 2019; 10(1):197. PMC: 6599379. DOI: 10.1186/s13287-019-1309-7. View

13.

Muruganandan S, Roman A, Sinal C . Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci. 2008; 66(2):236-53. PMC: 11131547. DOI: 10.1007/s00018-008-8429-z. View

14.

Mevel R, Draper J, Lie-A-Ling M, Kouskoff V, Lacaud G . RUNX transcription factors: orchestrators of development. Development. 2019; 146(17). DOI: 10.1242/dev.148296. View

15.

Brommage R, Liu J, Powell D . Skeletal phenotypes in secreted frizzled-related protein 4 gene knockout mice mimic skeletal architectural abnormalities in subjects with Pyle's disease from SFRP4 mutations. Bone Res. 2023; 11(1):9. PMC: 9941579. DOI: 10.1038/s41413-022-00242-9. View

16.

Cao B, Yang W, Jin Y, Zhang M, He T, Zhan Q . Silencing NKD2 by Promoter Region Hypermethylation Promotes Esophageal Cancer Progression by Activating Wnt Signaling. J Thorac Oncol. 2016; 11(11):1912-1926. DOI: 10.1016/j.jtho.2016.06.015. View

17.

Guo L, Li X, Tang Q . Transcriptional regulation of adipocyte differentiation: a central role for CCAAT/enhancer-binding protein (C/EBP) β. J Biol Chem. 2014; 290(2):755-61. PMC: 4294498. DOI: 10.1074/jbc.R114.619957. View

18.

Long X, Ortiz-Vega S, Lin Y, Avruch J . Rheb binding to mammalian target of rapamycin (mTOR) is regulated by amino acid sufficiency. J Biol Chem. 2005; 280(25):23433-6. DOI: 10.1074/jbc.C500169200. View

19.

Baron R, Kneissel M . WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat Med. 2013; 19(2):179-92. DOI: 10.1038/nm.3074. View

20.

Guan H, Zhang J, Luan J, Xu H, Huang Z, Yu Q . Secreted Frizzled Related Proteins in Cardiovascular and Metabolic Diseases. Front Endocrinol (Lausanne). 2021; 12:712217. PMC: 8417734. DOI: 10.3389/fendo.2021.712217. View